Pnc Financial Services Group, Inc. Summit Therapeutics Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 470 shares of SMMT stock, worth $9,019. This represents 0.0% of its overall portfolio holdings.
Number of Shares
470
Previous 45
944.44%
Holding current value
$9,019
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SMMT
# of Institutions
193Shares Held
75.8MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$469 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$210 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$152 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$104 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$66.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.86B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...